MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0042815
Kremoint Pharma Private Limited - pharma in Ambernath, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹64.72 Cr
▲ 12% YoY
Net profit · FY 2025
₹12 Cr
Net margin 18.5%
EBITDA · FY 2025
₹18.29 Cr
EBITDA margin 28.3%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹1.01 Cr
Satisfied ₹42.29 Cr
Company age
34 yrs
Est. 1992
Employees · EPFO
121
Provident fund records
About Kremoint Pharma Private Limited
Data last updated:
Kremoint Pharma Private Limited is a private limited company based in Ambernath, Maharashtra, India, a subsidiary of Bliss Gvs Pharma Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1992PTC066737. Its GSTIN is 27AABCK2940F1ZS (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Bhadresh Keshavji Thakkar (Managing Director) and Vibha Gagan Sharma.
Its last annual general meeting (AGM) was held on 02 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 8 Additional Ambernath MIDC Opp. Anand Nagar Octroi Naka, Maharashtra, India – 421506.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.72 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹12 Cr (net margin 18.5%) and EBITDA of ₹18.29 Cr (EBITDA margin 28.3%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 11% over five years.
The company has about 121 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Kremoint Pharma. As per MCA filings, the company has open charges of ₹1.01 Cr and satisfied charges of ₹42.29 Cr on record. Court records list 12 cases involving the company, including 11 filed by the company and 1 filed against it. The company has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in June 2012. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Man Care Laboratories Private Limited with revenue of ₹65.62 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2022, listing 172 overdue payments to 12 micro and small suppliers.
Kremoint Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0042815). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kremointpharma.com.
Company details
CIN U24230MH1992PTC066737
Registration Number 066737
Incorporation Date 12 May 1992
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 02 July 2025
Date of Balance Sheet 31 March 2025
Parent Company Bliss Gvs Pharma Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0042815
Key People
Bhadresh Keshavji Thakkar Managing Director Vibha Gagan Sharma Director Vishal Vijay Rao Director Recognitions & Rankings of Kremoint Pharma
Contact details
Kremoint Pharma Private Limited's registered office is in Ambernath, Maharashtra. Its website is kremointpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 8 Additional Ambernath MIDC Opp. Anand Nagar Octroi Naka, Maharashtra, India – 421506
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kremoint Pharma Private Limited, buy the company report.
Comprehensive company report
Kremoint Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Kremoint Pharma operates one associated brand: Kremoint Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Traditional pharmaceutical company manufacturing and marketing variety of finished dosage forms | kremointpharma.com |
Business activity
The main business activity of Kremoint Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kremoint Pharma Private Limited, buy the company report.
Financials of Kremoint Pharma Private Limited
FY 2025 filings availableKremoint Pharma Private Limited reported revenue of ₹64.72 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹64.72 Cr ▲ 12%
Net profit · FY 2025
₹12 Cr margin 18.5%
EBITDA · FY 2025
₹18.29 Cr margin 28.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 9%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 11%
5 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 12% growth in the latest year. EBITDA rose 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.3% | ||||
| Net Profit Margin | 18.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kremoint Pharma Private Limited, buy the company report.
Board of directors of Kremoint Pharma Private Limited
Kremoint Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhadresh Keshavji Thakkar | Managing Director | 12 May 1992 | 34 Years 5 Months | Current |
| Vibha Gagan Sharma | Director | 12 Jun 2020 | 6 Years 4 Months | Current |
| Vishal Vijay Rao | Director | 15 Jan 2025 | 1 Years 9 Months | Current |
| Shruti Vishal Rao Also directs: GVSK LLP, Bliss GVS Pharma Limited | Director | 20 Jul 2024 | 2 Years 3 Months | Current |
| Yesha Bhadresh Thakkar Also directs: Eipii Exports Private Limited | Director | 20 Jul 2024 | 2 Years 3 Months | Current |
Peer comparison
Kremoint Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Man Care Laboratories Private Limited | ₹65.62 Cr (FY 2025) | 31.0% | Ranchi, Jharkhand, India | |||
| Storks Medi-Tek Private Limited | ₹65.43 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| Valary Lab Private Limited | ₹65.12 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Kremoint Pharma Private Limitedthis company | ₹64.72 Cr (FY 2025) | ₹12 Cr | 18.5% | 12.0% | 121 | Ambernath, Maharashtra, India |
| Biovivid Labs Pharmaceuticals Private Limited | ₹64.61 Cr (FY 2025) | 121.0% | Delhi, India | |||
| Asiatic Drugs and Pharmaceuticals Private Limited | ₹64.49 Cr (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Vision Parenteral Private Limited | ₹64.47 Cr (FY 2025) | 8.0% | Gorakhpur, Uttar Pradesh, India | |||
| Astal Laboratories Limited | ₹64.36 Cr (FY 2025) | 172.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Kremoint Pharma Private Limited, buy the company report.
Auditor
Kremoint Pharma Private Limited is audited by Panachand K Shah & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Panachand K Shah & Co. | FY 2022 | 107271W |
Shareholding
The shareholding of Kremoint Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kremoint Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.01 Cr
Satisfied charges
₹42.29 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Jul 2023 | 100750652 | Others | ₹1 Lakh | Open | |
| 27 May 2023 | 100734975 | Others | ₹1 Cr | Open | |
| 08 Jan 2025 | 101039250 | Others | ₹4 Cr | Satisfied | |
| 02 Feb 2024 | 100867784 | Others | ₹5 Cr | Satisfied | |
| 25 Feb 2020 | 100351620 | Hdfc Bank Limited | ₹33.95 Lakh | Satisfied |
To see the full charge records of Kremoint Pharma Private Limited, buy the company report.
Total charge records: 16 View all charges
Deals & funding
Kremoint Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in June 2012.
Total deals
5
Secondary share transfers
4
Acquisition
1
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2012 | Acquisition | Undisclosed | Buyer: Bliss GVS Pharma Limited |
| Mar 2012 | Secondary share transfer | Undisclosed | Buyer: Bliss GVS Pharma Limited Seller: 4 individuals |
| Jul 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Sep 2005 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Kremoint Pharma Private Limited has 12 court cases on record: 11 filed by Kremoint Pharma, 1 filed against it. All cases are disposed.
Total cases
12
Filed by the company
11
Filed against the company
1
Disposed
12
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 0 | 0 |
| NCLT | 5 | 1 | 0 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Mumbai | Court case (COMP.APPL) | Filed by the company against Eco Rich Cosmetic Private Limited & Ors | Disposed |
| NCLT, Mumbai | Company petition | Filed against the company by individuals | Disposed |
| NCLT, Mumbai | Court case (COMP.APPL) | Filed by the company against an individual | Disposed |
| NCLT, Mumbai | Company petition | Filed by the company against Eco Rich Cosmetic Private Limited & Ors | Disposed |
| District court, Thane, Maharashtra | Court case (Munci. Appeal) | Filed by the company against Aamernath Municipal Council | Disposed |
To see the full case history of Kremoint Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Kremoint Pharma Private Limited was last rated by Crisil on 02 Dec 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 02 Dec 2019 |
To see the full credit ratings and regulatory alerts of Kremoint Pharma Private Limited, buy the company report.
MSME payment delays
Kremoint Pharma Private Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 172 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pangaea Tradeteam Private Limited | |||
| Packeteer Private Limited | |||
| an individual supplier | |||
| Avita Poly Films Private Limited | |||
| Cheryl Laboratories Pvt Ltd |
To see the full MSME payment records of Kremoint Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Kremoint Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Eipii Exports Private Limited | U52100MH2014PTC259675 |
To see the full group structure of Kremoint Pharma Private Limited, buy the company report.
Employees & EPFO
Kremoint Pharma Private Limited has a workforce of 121 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
121
Active EPFO establishments
1
Employee growth
6.14%
GST
Kremoint Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCK2940F1ZS | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kremoint Pharma Private Limited, buy the company report.
Recent activity
Kremoint Pharma Private Limited has 13 board changes on record since 1992: 9 appointments and 4 cessations. The latest: Gagan Harsh Sharma ceased to be Director on 06 Nov 2025.
Ceased
Gagan Harsh Sharma ceased to be Director.
Charges
A charge registered on 02 Feb 2024 via Charge ID 100867784 with Others was fully satisfied on 04 Nov 2025.
Charges
A charge registered on 08 Jan 2025 via Charge ID 101039250 with Others was fully satisfied on 06 Sep 2025.
AGM
Kremoint Pharma Private Limited last Annual general meeting of members was held on 02 Jul 2025 as per latest MCA records.
Filing
Kremoint Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Vishal Vijay Rao was appointed as Director.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 101039250 was registered on 08 Jan 2025.
Appointed
Shruti Vishal Rao was appointed as Director.
Appointed
Yesha Bhadresh Thakkar was appointed as Director.
Charges
A charge with Others amounted to Rs. 500.00 Lakh with Charge ID 100867784 was registered on 02 Feb 2024.
Charges
A charge with Others amounted to Rs. 1.00 Lakh with Charge ID 100750652 was registered on 11 Jul 2023.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 100734975 was registered on 27 May 2023.
39 earlier events are in the company report.
Frequently asked questions
Kremoint Pharma is an active private limited company based in Ambernath, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 1992 (34+ years old) and is registered under CIN U24230MH1992PTC066737.
Kremoint Pharma has 5 current directors:
- Bhadresh Keshavji Thakkar - Managing Director
- Vibha Gagan Sharma - Director
- Vishal Vijay Rao - Director
- Shruti Vishal Rao - Director
- Yesha Bhadresh Thakkar - Director
The latest financial statements of Kremoint Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 02 July 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kremoint Pharma is 27AABCK2940F1ZS, registered in Maharashtra.
The CIN (Corporate Identification Number) of Kremoint Pharma is U24230MH1992PTC066737. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kremoint Pharma has 12 court cases on record: 11 filed by the company and 1 filed against it. Most are in the district courts.
Kremoint Pharma was incorporated on 12 May 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Kremoint Pharma has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in June 2012.
The peers of Kremoint Pharma by revenue are Man Care Laboratories Private Limited, Storks Medi-Tek Private Limited, Valary Lab Private Limited, Biovivid Labs Pharmaceuticals Private Limited, Asiatic Drugs and Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gagan Harsh Sharma ceased to be Director on 06 Nov 2025. Vishal Vijay Rao was appointed as Director on 15 Jan 2025. Shruti Vishal Rao was appointed as Director on 20 Jul 2024. Kremoint Pharma has 13 board changes on record in total.
Yes, Kremoint Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0042815).
Kremoint Pharma has 6 MSME Form 1 returns on record between 2019 and 2022, listing 172 overdue payments to 12 micro and small suppliers. The latest return was filed on 30 Oct 2022.